Metabolic Syndrome
Conditions
Keywords
Metabolic syndrome, Primary prevention, Diabetes, Cardiovascular disease, Patient education
Brief summary
The aim of our study is to see if people with metabolic syndrome who attend a group education programme based on lifestyle changes (dietary and increased physical activity) can lessen their risk of having diabetes, heart disease and strokes in the future.
Detailed description
People who have a combination of risk factors termed metabolic syndrome are at increased risk of developing diabetes, heart disease and strokes. Metabolic syndrome is a major public health concern requiring urgent action because 25% of the adult UK population fulfil the criteria, and this will increase as people continue to be less active and levels of overweight and obesity rise. The aim of our study is to see if people with metabolic syndrome who attend a structured group education programme based on lifestyle changes (dietary and increased physical activity) can lessen their risk of having diabetes and cardiovascular disease in the future. Overall, we hope to show that this type of education reduces the number of people who have metabolic syndrome. Subjects recruited with metabolic syndrome will be randomised to intervention or control arms. The intervention arm will receive group education and the control group will receive routine care. The results will inform primary prevention strategies in people from varied ethnic backgrounds who are at high risk of developing type-2 diabetes and cardiovascular disease.
Interventions
BEHAVIORALGroup lifestyle education
Structured group education programme based on lifestyle changes (dietary and increased physical activity)
Sponsors
University Hospitals, Leicester
University of Leicester
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
40 Years to 74 Years
Healthy volunteers
No
Inclusion criteria
* Aged 40 - 74 years inclusive * Registered with a general practice in Leicester City or Leicester County Primary Care Trust * Availability of data to allow diagnosis of MetS (IDF criteria) collected at a screening visit
Exclusion criteria
* Previous diagnosis of T2DM, CVD (stroke/cerebrovascular accident, transient ischaemic attack), peripheral arterial disease, or coronary heart disease (angina, myocardial infarction, coronary artery bypass surgery, angioplasty) * Life-limiting terminal illness * Pregnancy and/or breast feeding * Lack of capacity to give informed consent because of serious mental health problems or learning disability. * People who are housebound * Patients residing in nursing/care homes * Individuals who are unable to speak and understand English. (The intervention will be made appropriate for ethnically diverse populations, but individuals who are unable to understand, speak and read English will be excluded at this stage. However, if the self-management programme is found to be successful we would adapt it for non-English speakers.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of people in the intervention and control groups with prevalent metabolic syndrome according to the IDF criteria. | 12 months follow-up. |
Secondary
| Measure | Time frame |
|---|---|
| Changes in individual components of the metabolic syndrome (fasting plasma glucose, triglycerides, HDL cholesterol, blood pressure, waist circumference), and 2 hour glucose | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| Changes in biomarkers (hs-CRP, adiponectin, and insulin) | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| Changes in physical activity as measured by IPAQ and pedometer | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| Changes in dietary/nutritional intake measured by DINE | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| The prevalence of metabolic syndrome according to NCEP criteria | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| Changes in quality of life as measured by EuroQol EQ-5D | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| Changes in depression/anxiety as measured by HADS | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| Changes in general self-efficacy as measured by GSE | Compared at baseline versus 12 months, and for the intervention group versus the control group |
| Changes in Framingham risk score | Compared at baseline versus 12 months, and for the intervention group versus the control group |
Countries
United Kingdom
Outcome results
None listed